728 x 90

Latest Health Posts

  • EzXADoqVkAMLeFH.jpg
    All above 18 allowed from 1st May : COVID-19 vaccines, Myths busted

    The COVID-19 pandemic has posed multiple substantial challenges, affecting not only public health but also economic systems, socio-cultural patterns, and political institutions. But it seems, even the crack of doom comes with a silver lining and the effectiveness of vaccines is now clearly visible in global charts. The myths around the vaccines are creating unnecessary panic, we bust some of these myths here.

  • coronavirus_seecond_wave_full_analysis.jpg
    The second wave is all set to hit India-how scared should we be?

    While the western world already saw an unabated rise in COVID-19 cases last winter, India seems to have arrived in the red zone now. In its highest daily spike of 2021, India reported 46,951 fresh Covid-19 cases in a single day pushing the overall tally to 11,646,081. Experts are already of the opinion that there's no reason we should not expect a second wave following the trajectory of infections in other countries.

  • Bharat-Biotech-Covaxin-gets-global-recognition.jpg
    India’s Covaxin published at Lancet, strikes global deals with USA and Brazil

    Bharat Biotech's Covaxin is yet to announce its Phase III results, however it has already struck deals with Brazil and USA to supply the vaccine. This comes after the famous British medical journal, Lancet, published a study on the effects of Covaxin, and said that the vaccine doses were well tolerated and only moderate vaccine-related adverse events were encountered. The randomised study was carried on 375 participants between the age of 18-55 across the country.

  • DCGI-gives-emergency-use-approval-to-Covaxin-Covishield-vaccines_public.jpg
    Covaxin or Covishield : Which vaccine to go for?

    India's drugs regulator DCGI has approved Oxford-Serum Institute's Covishield and Bharat Biotech's Covaxin for restricted emergency-use. While experts are alarmed at the grant of regulatory approval of Covaxin in spite of the lack of efficacy data, Covishield attracts a distinct concern altogether. These concerns however are with every vaccine out there in the world. It doesn’t demote the importance of fight against COVID-19 that India has begun with two desi vaccines.

  • diffrent-coronavirus-vaccine-price-and-compare.jpg
    Moderna, Pfizer, AstraZeneca or Covaxin : Which Vaccine fares better?

    Moderna was the second company to release promising preliminary data on a COVID-19 vaccine after Pfizer, in collaboration with BioNTech, reported that its vaccine was more than 90 percent effective in early results. To add to the spices, U.K.-based pharmaceutical company AstraZeneca has developed a vaccine with the University of Oxford, that showed an average efficacy of 70% in preventing COVID-19, according to the company. Which among these fares better?

  • baby-formula.jpg
    All you need to know about ancestral and modern breastfeeding practices

    A newborn’s health is the prime concern for the Parents, breast milk being the essential component for the well-being and growth of the child. In this article we wade through some myths and facts associated with the practice of Breastfeeding.


Page 1 of 5


  • Subscribe


Recent Post